Description
Turoctocog alfa (Factor VIII recombinante humano) 250 UI
cáncer de mama avanzado en mujeres premenopáusicas y endometriosis
Ingredientes activos según formulación del producto (600 mg por tableta)
Cada jeringa contiene 50 mg de etanercept
VITREX N CAP. 1.75 G. FCO. C/30 MESILATO DE DOXAZOSINA Turoctocog alfa (Factor VIII recombinanteSUSTANCIA: VITREX N CAP. 1. 75 G. FCO. C 30 FABRICANTE: NATUREX
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
